FDA

Regulating the invisible hand: Inside the FDA's AI playbook
Pharmaphorum
Thu, 04/10/25 - 11:19 am
FDA
regulatory
artificial intelligence
Tariffs are just part of pharma's Wall Street tumble
Axios
Wed, 04/9/25 - 11:16 am
pharma stocks
tariffs
FDA
regulatory
DOGE
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
Cure Today
Tue, 04/8/25 - 10:49 pm
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
FDA
Ex-official says he was forced out of FDA after trying to protect vaccine safety data from RFK Jr.
AP News
Tue, 04/8/25 - 11:48 am
FDA
Peter Marks
Robert F Kennedy Jr.
vaccines
safety data
FDA clears CureVac’s IND application for Phase I lung cancer trial
Clinical Trials Arena
Tue, 04/8/25 - 11:39 am
FDA
CureVac
CVHNLC
squamous non-small cell lung cancer
KalVista, awaiting FDA call on HAE drug, sells Japanese rights to Kaken in $22M deal
Fierce Biotech
Tue, 04/8/25 - 11:37 am
KalVista
FDA
HAE
sebetralstat
Japan
Kaken Pharma
FDA nod broadens use of Brainomix's stroke AI
Pharmaphorum
Tue, 04/8/25 - 11:14 am
Brainomix
stroke
artificial intelligence
FDA
Medtech
imaging
'A slow-moving catastrophe': FDA cuts are like firing all hospital staff except doctors, Janet Woodcock says
Fierce Biotech
Mon, 04/7/25 - 11:32 pm
FDA
layoffs
Janet Woodcock
Donald Trump
Trump layoffs begin to erode FDA drug review system
Investing.com
Fri, 04/4/25 - 09:59 am
FDA
drug reviews
Donald Trump
Amgen stock rises following FDA approval of Uplinza
Investing.com
Thu, 04/3/25 - 10:18 pm
Amgen
Uplinza
FDA
immunoglobulin G4-related disease
FDA misses approval deadline for Novavax’s COVID-19 vaccine
BioPharma Dive
Thu, 04/3/25 - 11:31 am
FDA
Novavax
vaccines
COVID-19
chromatin regulatory system
FDA Grants Fast Track Designation to Biogen’s Novel Alzheimer Disease Drug Candidate
Pharm Exec
Thu, 04/3/25 - 11:28 am
Biogen
BIIB080
FDA
fast track
Alzheimer's disease
Aldeyra’s dry eye drug suffers second FDA rejection, but imminent data spur hope of fast recovery
Fierce Biotech
Thu, 04/3/25 - 11:21 am
Aldeyra Therapeutics
dry eye disease
FDA
reproxalap
Novartis Has A Slight Edge On Travere — Why Analysts Aren't Worried
Investors Business Daily
Thu, 04/3/25 - 11:17 am
Novartis
Travere Therapeutics
FDA
kidney disease
atrasentan
FDA’s Chief Medical Officer Hilary Marston is out amid mass layoffs
Fierce Biotech
Wed, 04/2/25 - 11:31 am
FDA
regulatory
Hilary Marston
Texas judge overturns FDA’s lab developed test regulation, siding with industry groups
Medtech Dive
Wed, 04/2/25 - 11:26 am
Texas
legal
lab-developed tests
Medtech
FDA
diagnostics
Is the FDA ‘finished’? Leadership drain hits agency hard.
Pharma Voice
Wed, 04/2/25 - 11:21 am
FDA
regulatory
layoffs
Pharma stocks sink after ouster of top FDA vaccine regulator
MSN/Reuters
Mon, 03/31/25 - 11:05 am
pharma stocks
FDA
Peter Marks
Robert F Kennedy Jr.
FDA broadens use of Novartis’ radiopharma drug Pluvicto
BioPharma Dive
Sun, 03/30/25 - 10:36 pm
Novartis
Pluvicto
FDA
prostate cancer
radiopharmaceuticals
Peter Marks, FDA’s top vaccine official, resigns
BioPharma Dive
Sun, 03/30/25 - 10:29 pm
Peter Marks
FDA
vaccines
HHS
Robert F Kennedy Jr.

Pages